In the face of pressure from declining sales revenues, xianxi has opted for a proactive price reduction strategy. On 9 august 2024, in liaoning province, the company announced a reduction of 89. 51 per cent in the price of sodium phosphate injected in the diocese. Despite this, the price reduction is much higher than the price selected for the same product collection. The choice between a guaranteed market and a guaranteed price seems to be a dilemma in the case of cactus。
Unusual price increases
The sodium des phosphate, which is used mainly for allergies and self-immuno-inflammatory diseases, occupies an important place in primary hospitals. At the same time, sodium phosphate injection fluids are also a national catalogue of essential medicines and a national catalogue of medicinal products。
The sodium phosphate injection fluid was first developed by merck and approved for listing by fda in 1959. Merck's original medicine has been withdrawn from the market. One of the reference formulations recommended by the national bureau of medicine is an internationally recognized equivalent drug from the united states company fda orange, fresenius kabi usa llc, and an original product listed by aspen in the united kingdom and the european union。
At present, more than 100 enterprises in the country have permits for the manufacture of sodium phosphate injections, but only a little more than one tenth of the enterprises evaluated through consistency. Sodium phosphate injections from the epinephrine industry were approved for sale in the country in january 2022, along with the chengdube drug industry. Since then, zhejiang xianxiang, tianjin kim yu, the national pharmaceutical corporation, guangzhou green cross, hubei tianzhian, the south-west pharmaceuticals and henan yunhong。
During the new coronary epidemic, sugar cortex hormones, such as dixemeson, played a significant role in the rescue of persons with acute illnesses, and the who guide recommended that sugar cortex hormones, such as dixemeson, be used for new cortex or acute diseases. This has led to a surge in market demand for sodium phosphate injection fluids and a consequent significant increase in sales。
The data show that sales of sodium phosphate injection fluids in our compound for the first time in 2021 went through the hundreds of billions of yuan, an increase of 685. 1 per cent over the same period; sales amounted to 499 million yuan in 2022, an increase of 302. 4 per cent over 2021; and sales of sodium phosphate injection fluids in the compound amounted to 916 million yuan in 2023。
However, while market sales have increased significantly, sodium phosphate injections have experienced an unusual wave of price increases and interruptions, and in some areas the price of sodium phosphate injections has risen to between a dozen and a hundred dollars。
In 2023, the price of sodium phosphate injections varied between regions and the price increases were reported. In liaoning, there were multiple doses of sodium phosphate injection from a hospital, while doctors from guangxi hospital indicated that 56 yuan had been used. The head of a hospital in hunanzhou stated that the original price of sodium phosphate injection was $0. 35/salary, increasing to $98. 76/salary in 2022, an increase of nearly 282 times。
Behind the soaring prices, pharmaceutical companies were penalized for the price of injections of phosphorus on the ground. The sixth series of cases of offences involving medicines and medical supplies, published by the general directorate of state markets, showed that on 16 january 2023, the south-east state medical company of the state drug control unit in guizhou conducted a law enforcement inspection of the south-east state medicine company ltd. The company was found to have purchased $0. 58/salary in november 2022, $0. 63/salary in november 2022, $0. 7/salary in december 2022, raised the sale price to $0. 8/salary in january 2023, an increase of $20. 69 per cent in the purchase price and an increase of $155. 56 per cent in the sale price。
At the time of the incident, 50,000 disemidophosphate injections procured by the national drug control unit, south eastern county medicine company ltd. Had been sold out of 38780 for a sale of $380044. Despite the increase in the cost of the company's medicines, the price increase was significantly higher than the cost increase, in violation of article 14, paragraph 3, of the prices act, which constituted an offence to raise the price. On 15 february 2023, the superintendence of the market of the south-east province imposed an administrative fine of $700,000 in accordance with the law。
Collection brings a reasonable price reduction
As an old drug, sodium disemison phosphate injections were not originally produced at high cost and sold cheaply, and why have they begun to rise wildly in recent years
“easier shortages and higher prices for first aid drugs are not new, and the prices of many drugs are rising year by year.” a senior practitioner of pharmacology cro told the wigand times journalist that the state adopted a low-cost model to protect patients ' rights and interests. However, such long-term low prices also discourage pharmaceutical incentives, with operating costs rising and production enterprises becoming unsupplied. The “two-vote” system has increased the bargaining power of raw-material pharmacies, coupled with the hormonal variety of raw-materials, the number of domestic producers is not high, and the demand for first-aid drugs by buyers such as hospitals is acute and, at one time, there is a shortage of medicines。
In addition, some pharmacies, lured by high profits, use loopholes in market regulation to control market supplies, including through monopolies, thus manipulating the rising prices of emergency drugs。
In response to the increase in the price and supply of some clinical emergency and vulnerable drugs, the objective of securing supplies against reasonable price reductions is to stabilize corporate expectations through “carrying” procurement。
In march 2022, under the leadership of guangdong, six provinces (troops) of shanxi, henan and jiangxi participated in the collection of common chronic drugs in the guangdong union. According to the published results, the lowest price was 1 ml: 2. 0 mg disemison sodium phosphate injector fluid from tianjin gin gin yu pharmaceutical industry ltd. The lowest price was 0. 185 yuan/bottle. However, in other areas not covered by the coalition, sodium phosphate injections were not reduced。
In november 2023, sodium phosphate injectors entered the ninth batch of national drug collections, not only the largest purchase of the ninth batch, amounting to 2,055 million yuan, but also the highest reduction of 98 per cent. The sodium phosphate injection (1ml:5mg) was selected for 7 drug companies at a price of $0. 23/s. Of these, the decrease in henan yunhon pharmaceuticals was more than 97 per cent and the decrease in the pharmaceutical capacity of the national pharmaceutical group was more than 96 per cent。
